pharma news today glp-1 obesity drug Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat and other weight-related conditions How Supply and Demand for

Semaglutide changes the way the body processes food and stores energy, leading to metabolic adaptations that can cause temporary fatigue

For you as an investor, the cluster of legal and regulatory actions creates a question mark around the durability of this newer part of the NYSE:HIMS business

Its important to understand that for Wegovy, only the marked doses on the single-use, fixed-dose pens are approved for use and represent an authentic FDA-approved medicine. Eli Lilly says it doesnt have any data on the benefits or risks of microdosing tirzepatide, the active ingredient in Zepbound and Mounjaro

The drugs have shown benefits beyond weight loss, such as for heart health and sleep apnea, but their side effects can include severe gastrointestinal symptoms and rare incidents of pancreatitis, depression and blindness

Moving Forward If you're considering a GLP-1 medication, here's what you need to know in plain terms: Buying these medications online without a prescription is not safe Taking them without proper screening means you may not know if they're safe for you Managing dosing on your own significantly increases your risk of side effects and poor results Without nutritional guidance, you may lose muscle instead of fat Long-term success requires more than a prescription